Cleared Special

K141925 - TOTAL PROTEIN URINE/CSF GEN.3

K141925 is the FDA 510(k) clearance for TOTAL PROTEIN URINE/CSF GEN.3 by Roche Diagnostics Operations (Rdo). It is a Class 1 Chemistry device (product code JIQ) cleared through the Special 510(k) pathway after a 146-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
146d
Days
Class 1
Risk

K141925 is an FDA 510(k) clearance for the TOTAL PROTEIN URINE/CSF GEN.3. Classified as Turbidimetric Method, Protein Or Albumin (urinary, Non-quant.) (product code JIQ), Class I - General Controls.

Submitted by Roche Diagnostics Operations (Rdo) (Indianapolis, US). The FDA issued a Cleared decision on December 9, 2014 after a review of 146 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1645 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Roche Diagnostics Operations (Rdo) devices

Submission Details

510(k) Number K141925 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 16, 2014
Decision Date December 09, 2014
Days to Decision 146 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
58d slower than avg
Panel avg: 88d · This submission: 146d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code JIQ Turbidimetric Method, Protein Or Albumin (urinary, Non-quant.)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1645
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JIQ Turbidimetric Method, Protein Or Albumin (urinary, Non-quant.)

Devices cleared under the same product code (JIQ) and FDA review panel - the closest regulatory comparables to K141925.
IMMAGE IMMUNOCHEMISTRY SYSTEM MICROALBUMIN (MA) REAGENT
K965035 · Beckman Instruments, Inc. · Apr 1997
WAKO MICRO-ALBUMIN B/WAKO MICRO ALBUMIN CALIBRATOR
K944664 · Wako Chemicals USA, Inc. · Feb 1995
WAKO(TM) MICRO-ALBUMIN
K902216 · Wako Chemicals USA, Inc. · Jun 1990
BECKMAN MA MICROALBUMIN REAGENT KIT
K895883 · Beckman Instruments, Inc. · Dec 1989
ALBUMIN SCREEN TEST
K870516 · Sclavo, Inc. · Oct 1987